BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6415371)

  • 1. Macrophage activation by Lactobacillus casei in mice.
    Kato I; Yokokura T; Mutai M
    Microbiol Immunol; 1983; 27(7):611-8. PubMed ID: 6415371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between increase in Ia-bearing macrophages and induction of T cell-dependent antitumor activity by Lactobacillus casei in mice.
    Kato I; Yokokura T; Mutai M
    Cancer Immunol Immunother; 1988; 26(3):215-21. PubMed ID: 3133111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei.
    Nomoto K; Miake S; Hashimoto S; Yokokura T; Mutai M; Yoshikai Y; Nomoto K
    J Clin Lab Immunol; 1985 Jun; 17(2):91-7. PubMed ID: 3930748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of host resistance against Listeria infection by Lactobacillus casei: activation of liver macrophages and peritoneal macrophages by Lactobacillus casei.
    Sato K; Saito H; Tomioka H
    Microbiol Immunol; 1988; 32(7):689-98. PubMed ID: 2848179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Lactobacillus casei on Pseudomonas aeruginosa infection in normal and dexamethasone-treated mice.
    Saito H; Watanabe T; Horikawa Y
    Microbiol Immunol; 1986; 30(3):249-59. PubMed ID: 3088397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of perorally administered lactobacilli on macrophage activation in mice.
    Perdigon G; de Macias ME; Alvarez S; Oliver G; de Ruiz Holgado AA
    Infect Immun; 1986 Aug; 53(2):404-10. PubMed ID: 3733223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of colony-stimulating activity in antitumor activity of Lactobacillus casei in mice.
    Shimizu T; Nomoto K; Yokokura T; Mutai M
    J Leukoc Biol; 1987 Sep; 42(3):204-12. PubMed ID: 3114399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo release of cytostatic factors from Lactobacillus casei-elicited peritoneal macrophages after stimulation with tumor cells and immunostimulants.
    Hashimoto S; Nomoto K; Nagaoka M; Yokokura T
    Cancer Immunol Immunother; 1987; 24(1):1-7. PubMed ID: 3102062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect of intrapleural administration of Lactobacillus casei in mice.
    Matsuzaki T; Yokokura T; Mutai M
    Cancer Immunol Immunother; 1988; 26(3):209-14. PubMed ID: 3133110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of Lactobacillus casei in mice.
    Kato I; Kobayashi S; Yokokura T; Mutai M
    Gan; 1981 Aug; 72(4):517-23. PubMed ID: 6796451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of tumoricidal peritoneal exudate cells by administration of Lactobacillus casei.
    Kato I; Yokokura T; Mutai M
    Int J Immunopharmacol; 1985; 7(1):103-9. PubMed ID: 3158616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus.
    Perdigón G; de Macias ME; Alvarez S; Oliver G; de Ruiz Holgado AP
    Immunology; 1988 Jan; 63(1):17-23. PubMed ID: 3123370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Augmentation of antitumor activity of Lactobacillus casei YIT 8018 (LC 9018) in combination with various antitumor drugs].
    Matsuzaki T; Kato I; Yokokura T; Mutai M
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):445-51. PubMed ID: 6200079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective and therapeutic efficacy of Lactobacillus casei against experimental murine infections due to Mycobacterium fortuitum complex.
    Saito H; Tomioka H; Nagashima K
    J Gen Microbiol; 1987 Oct; 133(10):2843-51. PubMed ID: 3130460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of mice against herpes simplex virus infection by a Lactobacillus casei preparation (LC 9018) in combination with inactivated viral antigen.
    Watanabe T; Saito H
    Microbiol Immunol; 1986; 30(2):111-22. PubMed ID: 3012292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary resistance induced in mice by Lactobacillus casei following infection with herpes simplex virus.
    Watanabe T; Yamori T
    Kansenshogaku Zasshi; 1989 Mar; 63(3):182-8. PubMed ID: 2475554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of host resistance against Listeria infection by Lactobacillus casei: role of macrophages.
    Sato K
    Infect Immun; 1984 May; 44(2):445-51. PubMed ID: 6425222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimetastatic effect of Lactobacillus casei YIT9018 (LC 9018) on a highly metastatic variant of B16 melanoma in C57BL/6J mice.
    Matsuzaki T; Yokokura T; Azuma I
    Cancer Immunol Immunother; 1987; 24(2):99-105. PubMed ID: 3103914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of Lactobacillus casei on Pseudomonas aeruginosa infection in mice.
    Miake S; Nomoto K; Yokokura T; Yoshikai Y; Mutai M; Nomoto K
    Infect Immun; 1985 May; 48(2):480-5. PubMed ID: 3921464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of host resistance against Listeria infection by Lactobacillus casei: efficacy of cell wall preparation of Lactobacillus casei.
    Sato K; Saito H; Tomioka H; Yokokura T
    Microbiol Immunol; 1988; 32(12):1189-200. PubMed ID: 2853287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.